Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Bilcare Ltd. is significantly underperforming compared to its peers across key financial metrics such as profitability, growth, and valuation. The company exhibits weak profitability with negative returns, high debt levels, and a high price-to-earnings ratio that does not justify its financial performance. In contrast, other companies in the sector demonstrate stronger financial health and growth potential, positioning them as more favorable investment opportunities.
Highest ROE at 22.49% and strong EPS growth at 70.05.
Outstanding revenue growth (YoY at 9.36%) and solid profitability metrics with high margins.
Low P/E ratio at 19.03 and high EPS growth, indicating strong value.